Clinical Trial Update: EVITA: Evaluation of VIP Feature in Pacemaker Patients [NA]

View source ↗

Summary

This clinical trial update reports on the EVITA study evaluating the VIP feature in pacemaker patients, funded by Abbott Medical Devices, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia

Snippet

Sponsor: Abbott Medical Devices | Conditions: Arrhythmia | NA | Status: COMPLETED